Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial.
Sinha SD, Bandi VK, Bheemareddy BR, Thakur P, Chary S, Mehta K, Pinnamareddy VR, Pandey R, Sreepada S, Durugkar S. Sinha SD, et al. Among authors: chary s. BMC Nephrol. 2019 Mar 13;20(1):90. doi: 10.1186/s12882-019-1209-1. BMC Nephrol. 2019. PMID: 30866856 Free PMC article. Clinical Trial.
A Prospective, Randomized, Multiple-Dose, Multi-Center, Comparative Clinical Study to Evaluate the Efficacy, Safety, Immunogenicity of a biosimilar Bevacizumab (Test product, Hetero) and Reference Medicinal Product (Bevacizumab, Roche) in Patients of Metastatic Colorectal Cancer.
Advani S, Biswas G, Sinha S, B B, Bandi VK, Naidu N, Thakur P, Chary S. Advani S, et al. Among authors: chary s. J Assoc Physicians India. 2018 Jun;66(6):55-59. J Assoc Physicians India. 2018. PMID: 31331137 Clinical Trial.
Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial.
Sinha SD, Bandi VK, Bheemareddy BR, Thakur P, Chary S, Mehta K, Pinnamareddy VR, Pandey R, Sreepada S, Durugkar S. Sinha SD, et al. Among authors: chary s. BMC Nephrol. 2019 Nov 19;20(1):415. doi: 10.1186/s12882-019-1515-7. BMC Nephrol. 2019. PMID: 31744458 Free PMC article.
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy.
Sinha S, Ghosh B, Bandyopadhyay S, Fatima F, Bandi VK, Thakur P, Reddy B, Chary S, Talluri L, Gupta A, Kale AR, Gupta AK, P AK, Reddy D, Mohammed Y, Shekar S, T S, Goni VG, Sharma V, Yeligod V. Sinha S, et al. Among authors: chary s. BMC Rheumatol. 2020 Jun 4;4:24. doi: 10.1186/s41927-020-00124-9. eCollection 2020. BMC Rheumatol. 2020. PMID: 32518895 Free PMC article.
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India.
Sinha S, Chary S, Reddy Bandi M, Thakur P, Talluri L, Reddy VK, Agarwal M, Naik K S, Azilsartan Study In Indian Adult Patients Of Essential Hypertension Investigators Azilehi Group. Sinha S, et al. Among authors: chary s. J Assoc Physicians India. 2021 Feb;69(2):35-39. J Assoc Physicians India. 2021. PMID: 33527809 Clinical Trial.
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India.
Sinha S, N K, Suram VK, Chary SS, Naik S, Singh VB, Jain MK, Suthar CP, Borthakur S, Sawardekar V, Sk N, Reddy N, Talluri L, Thakur P, Reddy M, Panapakam M, Vattipalli R. Sinha S, et al. Among authors: chary ss. Cureus. 2022 Nov 14;14(11):e31508. doi: 10.7759/cureus.31508. eCollection 2022 Nov. Cureus. 2022. PMID: 36532902 Free PMC article.
75 results